LUZVIMINDA ALEXANDER: Open Payments
NPI 1841632437 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,500 in 69 payments from 16 companies in 2025. Trend: 2023 $3,100 · 2024 $2,402 · 2025 $2,500
Food & beverage: $2,500
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $579 |
| Kestra Medical Technology Services, Inc. | 12 | $373 |
| ABIOMED | 7 | $324 |
| BridgeBio Pharma, Inc. | 9 | $267 |
| Novartis Pharmaceuticals Corporation | 10 | $220 |
| AstraZeneca Pharmaceuticals LP | 2 | $135 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $116 |
| PFIZER INC. | 5 | $107 |
| SCPHARMACEUTICALS INC. | 1 | $96 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
Products named: CARDIOMEMS, Assure WCD, Attruby, LEQVIO, LOKELMA, LifeVest, VYNDAQEL, AVEIR.
Industry payments across NV — which companies pay providers there.
